TITLE

Care of Patients Undergoing Extracorporeal Photopheresis to Treat Chronic Graft-Versus-Host Disease: Review of the Evidence

AUTHOR(S)
Woltz, Patricia; Castro, Kathleen; Park, Beatrice J.
PUB. DATE
December 2006
SOURCE
Clinical Journal of Oncology Nursing;Dec2006, Vol. 10 Issue 6, p795
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Late immune dysregulation following allogeneic hematopoietic cell transplantation (HCT) is known as chronic graft-versus-host disease (GVHD), which is a major cause of mortality and morbidity after HCT, and a rise in its incidence is predicted. Better therapies are being sought to manage chronic GVHD and limit patients' exposure to corticosteroids. Extracorporeal photopheresis (ECP), an immune-modulating therapy, has shown preliminary safety and efficacy in treating chronic GVHD. However, access to ECP is limited, care is costly, and the optimal frequency, duration, and durability of response are unknown. Although nurses who care for patients with chronic GVHD recognize its adverse impact on patients' quality of life, limited evidence exists about the selection of patients most likely to benefit from ECP therapy and from the supportive care provided to them. A multidisciplinary approach is needed to define the desired outcomes of ECP therapy and to determine the evidence base for nursing management approaches.
ACCESSION #
23294764

 

Related Articles

  • Stem cell source-dependent reconstitution of FOXP3+ T cells after pediatric SCT and the association with allo-reactive disease. Reubsaet, L L; de Pagter, A P J; van Baarle, D; Keukens, L; Nanlohy, N; Sanders, E A M; Prakken, B J; Boelens, J J; de Kleer, I M // Bone Marrow Transplantation;Apr2013, Vol. 48 Issue 4, p502 

    In adult patients, regulatory CD4+FOXP3+ T cells are suggested to have a role in the control of allo-reactive disease after hematopoietic SCT (HSCT). We compared CD4+FOXP3+ T-cell reconstitution after unrelated cord blood (UCB), matched unrelated donor (MUD) and matched sibling donor (MSD) HSCT...

  • Gut Toxicity During Hemopoietic Stem Cell Transplantation May Predict Acute Graft-Versus-Host Disease Severity in Patients. Jan-Erik Johansson; Tor Ekman // Digestive Diseases & Sciences;Sep2007, Vol. 52 Issue 9, p2340 

    Abstract  Graft-versus-host disease (GVHD) is the primary complication of allogeneic, hemopoietic, stem cell transplantation (HSCT). Murine models suggest that gut toxicity, induced by the intensive chemotherapy preceding hematopoietic stem cell infusion, aggravates systemic...

  • Invasive microsporidiosis in allogeneic haematopoietic SCT recipients. Ambrosioni, J.; van Delden, C.; Krause, K. H.; Bouchuiguir-Wafa, C.; Nagy, M.; Passweg, J.; Chalandon, Y. // Bone Marrow Transplantation;Jul2010, Vol. 45 Issue 7, p1249 

    The article presents a case study of a 49-year-old woman admitted for allo-hematopoietic stem cell transplantation (HSCT) from an unrelated donor human leukocyte allele (HLA) matched 9/10 to treat her Hodgkin's lymphoma (HL) 20 months prior to the admission. Treatments given to the patient...

  • Autologous blood pleurodesis for pneumothorax complicating graft-versus-host disease-related bronchiolitis obliterans. Chadwick, C.; Marven, S. M.; Vora, A. J. // Bone Marrow Transplantation;Feb2004, Vol. 33 Issue 4, p451 

    Summary:Bronchiolitis obliterans (BO) is a manifestation of chronic graft-versus-host disease (GVHD) after allogeneic haemopoietic stem cell transplantation. Complications associated with this include persistent air-leak syndromes such as pneumothorax. Many methods have been described for...

  • Twenty-year follow-up of a randomized trial comparing intraosseous and i.v. BM transplantation. Hägglund, H; Remberger, M; Ringden, O // Bone Marrow Transplantation;Dec2014, Vol. 49 Issue 12, p1541 

    The article discusses the follow-up of a randomized trial in 1998 which compares intraosseous (i.o.) and i.v. transplantation of allogeneic haematopoietic stem cells. The probability of chronic graft versus host disease (GVHD) was deemed similar to both transplantation. Induction of persistent...

  • Reduced-Intensity Stem Cell Transplantation for Hematological Malignancies: Current Status and the Future. Kato, Koji; Khaled, Yasser; Mineishi, Shin // Current Stem Cell Research & Therapy;May2007, Vol. 2 Issue 2, p149 

    Reduced-intensity stem cell transplantation (RIST) has opened a new era for hematopoietic stem cell transplantation (HSCT). It was developed based on the knowledge that graft-versus-tumor (GVT) effect is the main anti-tumor effect in allogeneic HSCT. Because RIST is associated with less...

  • Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients. Heining, C.; Spyridonidis, A.; Bernhardt, E.; Schulte-Mönting, J.; Behringer, D.; Grüllich, C.; Jakob, A.; Bertz, H.; Finke, J. // Bone Marrow Transplantation;May2007, Vol. 39 Issue 10, p613 

    Here we investigated the influence of parameters known before hematopoietic stem cell transplantation (HSCT) as well as the relevance of graft-versus-host disease (GvHD) and cytomegalovirus (CMV) reactivation on post transplant lymphocyte reconstitution in 148 patients treated in our institution...

  • Expression of α4β7 integrin on memory CD8+ T cells at the presentation of acute intestinal GVHD. Chen, Y-B; McDonough, S; Chen, H; Kennedy, J; Illiano, C; Attar, E C; Ballen, K K; Dey, B R; McAfee, S L; Jagasia, M; Soiffer, R; Spitzer, T R; Ritz, J // Bone Marrow Transplantation;Apr2013, Vol. 48 Issue 4, p598 

    Acute intestinal GVHD remains a major source of morbidity after allogeneic hematopoietic cell transplantation (HCT). α4β7 integrin is a cell surface molecule that mediates lymphocyte trafficking to intestinal tissue. In this analysis, peripheral blood was collected at the time of...

  • Low levels of 25-hydroxyvitamin D before allogeneic hematopoietic SCT correlate with the development of chronic GVHD. Glotzbecker, B; Ho, V T; Aldridge, J; Kim, H T; Horowitz, G; Ritz, J; Soiffer, R; Avigan, D; Rosenblatt, J // Bone Marrow Transplantation;Apr2013, Vol. 48 Issue 4, p593 

    Vitamin D, a hormone involved in bone and calcium homeostasis, has been shown to have potent immunomodulatory effects. We performed a retrospective cohort analysis to evaluate whether monohydroxyvitamin D levels before allogeneic hematopoietic SCT (HSCT) correlate with the risk of GVHD....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics